Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Natural Capsules Ltd (NATCAPSUQ) Share Price & Fundamentals

Company Overview

Founded Year

1993

Listed Year

1994

Headquarter

Bangalore, India

MD/CEO

Mr. Sunil L Mundra

Website

http://www.naturalcapsules.com

Company Facts

What we do

Natural Capsules Ltd manufactures hard gelatin and vegetarian capsule shells, supplying pharmaceutical and dietary supplement industries domestically and internationally.

Founded in

1,993

Market share

Second-largest gelatin capsule manufacturer in India, pioneering vegetarian capsules.

Problem solved

Provides high-quality capsule shells ensuring safe and efficient drug delivery to pharmaceutical customers worldwide.

Top clients or who we serve

Pharmaceutical and dietary supplement companies globally; serving both regulated and emerging markets.

Key management

Mr. Sunil L Mundra (Managing Director) among others with strong pharma industry experience.

Our journey and innovations

Founded 1993; pioneered vegetarian capsules in India; expanded manufacturing and innovations with latest generation capsule machines.

Where we operate

Exports to 28 countries across Africa, Americas, Asia, and Middle East; manufacturing in Bangalore and Puducherry, India.

Top products or what we offer

Hard gelatin capsules, vegetarian (HPMC) capsules, special variants, and steroidal APIs via subsidiary.

Top brands

No specific brands; flagship products include gelatin and cellulose capsules, expanding into steroidal APIs.

Raw materials needed

Gelatin, cellulose, specialized polymers, and raw materials for steroidal API synthesis.

Raw materials supplier

Not specified; likely specialized chemical suppliers and pharmaceutical-grade sources.

Recurring vs cyclical contribution

Capsules segment contributes majority recurring revenues; API segment currently smaller and developing.

Our industry position

Market leader in India’s capsule manufacturing; foraying into steroidal APIs with government incentives.

Financial highlights

FY25 consolidated revenue ₹169.21 crore with ₹0.62 crore profit after tax; capsules dominate revenue.

Geographical revenue split

Exports constitute 31% of revenues; major markets include Africa, North and South America, Middle East, and Asia.

Order book

-

Whats driving growth

Capacity expansion, technological upgrades, easing US tariffs, PLI incentives for API segment driving growth.

Our future plans

Complete installation of new HPMC lines and expand API commercial production; focus on regulated markets.

Our green promise

Practices include zero liquid discharge facility for API manufacturing and adherence to cGMP standards.

Our people and values

619 employees with focus on innovation, quality, compliance, and customer service excellence.

Key challenges ahead

Regulatory compliance, stabilizing API fermentation scale-up, temporary operational shutdowns affecting supply.

Interesting facts

First Indian manufacturer of vegetarian capsules; installed global fastest capsule machines; patented API processes.

Risks and strategy

Addressing regulatory challenges, mitigating scale-up delays with partnerships, focusing on regulated markets for stable growth.

Market Footprint

Top Clients

Top Clients

Pharmaceutical and dietary supplement companies globally; serving both regulated and emerging markets.

Top Products

Top Products

Hard gelatin capsules, vegetarian (HPMC) capsules, special variants, and steroidal APIs via subsidiary.

Price Movement & Share Holding

Today's High/Low

132.02139

52 Week High/Low

132.02234
Past Returns

1 week

-12.6%

1 month

-17.41%

3 month

-7.06%

1 year

-37.21%

3 year

-45.33%

5 year

-45.33%

Share Holding

Promoters

50.92%

FII

0.08%

DII

0%

Retail

39.79%

Others

9.21%

Company Overview

Founded Year

1993

Listed Year

1994

Headquarter

Bangalore, India

MD/CEO

Mr. Sunil L Mundra (Managing Director) among others with strong pharma industry experience.

Website

http://www.naturalcapsules.com

Price Movement & Share Holding

Today's High/Low

132.02139

52 Week High/Low

132.02234

Past Returns

1 week

-12.6%

1 month

-17.41%

3 month

-7.06%

1 year

-37.21%

3 year

-45.33%

5 year

-45.33%

Share Holding

Promoters

50.92%

FII

0.08%

DII

0%

Retail

39.79%

Others

9.21%

Company Facts

What we do

Natural Capsules Ltd manufactures hard gelatin and vegetarian capsule shells, supplying pharmaceutical and dietary supplement industries domestically and internationally.

Founded in

1993

Market share

Second-largest gelatin capsule manufacturer in India, pioneering vegetarian capsules.

Problem solved

Provides high-quality capsule shells ensuring safe and efficient drug delivery to pharmaceutical customers worldwide.

Top clients or who we serve

Pharmaceutical and dietary supplement companies globally; serving both regulated and emerging markets.

Key management

Mr. Sunil L Mundra (Managing Director) among others with strong pharma industry experience.

Our journey and innovations

Founded 1993; pioneered vegetarian capsules in India; expanded manufacturing and innovations with latest generation capsule machines.

Where we operate

Exports to 28 countries across Africa, Americas, Asia, and Middle East; manufacturing in Bangalore and Puducherry, India.

Top products or what we offer

Hard gelatin capsules, vegetarian (HPMC) capsules, special variants, and steroidal APIs via subsidiary.

Top brands

No specific brands; flagship products include gelatin and cellulose capsules, expanding into steroidal APIs.

Raw materials needed

Gelatin, cellulose, specialized polymers, and raw materials for steroidal API synthesis.

Raw materials supplier

Not specified; likely specialized chemical suppliers and pharmaceutical-grade sources.

Recurring vs cyclical contribution

Capsules segment contributes majority recurring revenues; API segment currently smaller and developing.

Our industry position

Market leader in India’s capsule manufacturing; foraying into steroidal APIs with government incentives.

Financial highlights

FY25 consolidated revenue ₹169.21 crore with ₹0.62 crore profit after tax; capsules dominate revenue.

Geographical revenue split

Exports constitute 31% of revenues; major markets include Africa, North and South America, Middle East, and Asia.

Whats driving growth

Capacity expansion, technological upgrades, easing US tariffs, PLI incentives for API segment driving growth.

Our future plans

Complete installation of new HPMC lines and expand API commercial production; focus on regulated markets.

Our green promise

Practices include zero liquid discharge facility for API manufacturing and adherence to cGMP standards.

Our people and values

619 employees with focus on innovation, quality, compliance, and customer service excellence.

Key challenges ahead

Regulatory compliance, stabilizing API fermentation scale-up, temporary operational shutdowns affecting supply.

Interesting facts

First Indian manufacturer of vegetarian capsules; installed global fastest capsule machines; patented API processes.

Risks and strategy

Addressing regulatory challenges, mitigating scale-up delays with partnerships, focusing on regulated markets for stable growth.

Market Footprint

Top Clients

Top Clients

Pharmaceutical and dietary supplement companies globally; serving both regulated and emerging markets.

Top Products

Top Products

Hard gelatin capsules, vegetarian (HPMC) capsules, special variants, and steroidal APIs via subsidiary.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions